Therapeutic Options for Patients with Severe β-Thalassemia: The Need for Globin Gene Therapy

This publication has 56 references indexed in Scilit:

• Gene transfer in humans using a conditionally replicating lentiviral vector
  Proceedings of the National Academy of Sciences, 2006
• Outcomes of Transplantation with Related- and Unrelated-Donor Stem Cells in Children with Severe Thalassemia
  Transplantation and Cellular Therapy, 2006
• Oral chelators deferasirox and deferiprone for transfusional iron overload in thalassemia major: new data, new questions
  Blood, 2006
• Caring for Adults with Thalassemia in a Pediatric World
  Annals of the New York Academy of Sciences, 2005
• Retroviral DNA Integration: ASLV, HIV, and MLV Show Distinct Target Site Preferences
  PLoS Biology, 2004
• Complications of β-thalassemia major in North America
  Blood, 2004
• Occurrence of leukaemia following gene therapy of X-linked SCID
  Nature Reviews Cancer, 2003
• Effectiveness and safety of ICL670 in iron-loaded patients with thalassaemia: a randomised, double-blind, placebo-controlled, dose-escalation trial
  The Lancet, 2003
• Survival in β-thalassaemia major in the UK: data from the UK Thalassaemia Register
  The Lancet, 2000
• Bone Marrow Transplantation in Patients with Thalassemia
  New England Journal of Medicine, 1990